Galectin Therapeutics Inc. (GALT)

[Amatuer17]

Thanks for the article

Interesting to see mention of GR-MD-02 as GALT FX trial is over and it failed. The current trial is CX


"For now, Jim doesn’t require a transplant. He works hard to stay in shape and maintain good health, ever hopeful that his NASH will be kept in check. After 33 years working for Southern California Gas Company, the retiree appreciates not having to drive 160 miles round-trip each day to his job. Instead, he drives to Cedars-Sinai twice a month for the clinical trial in which 66% of participants are infused with GR-MD-02—an experimental drug that targets liver fibrosis."